Z
Zubairi Djoerban
Researcher at University of Indonesia
Publications - 27
Citations - 208
Zubairi Djoerban is an academic researcher from University of Indonesia. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 22 publications receiving 160 citations.
Papers
More filters
Journal ArticleDOI
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
William C. Miller,Irving F. Hoffman,Brett Hanscom,Tran Viet Ha,Kostyantyn Dumchev,Zubairi Djoerban,Scott Rose,Carl A. Latkin,David S. Metzger,Kathryn E. Lancaster,Vivian F. Go,Sergii Dvoriak,Katie R. Mollan,Sarah A. Reifeis,Estelle Piwowar-Manning,Paul G. Richardson,Michael G. Hudgens,Erica L. Hamilton,Jeremy Sugarman,Susan H. Eshleman,Hepa Susami,Viet Anh Chu,Samsuridjal Djauzi,Tetiana Kiriazova,Duong D Bui,Steffanie A. Strathdee,David N. Burns +26 more
TL;DR: Evidence is provided that a flexible, scalable intervention increases ART and MAT use and reduces mortality among PWID and the feasibility of a future randomised controlled trial is assessed.
Journal Article
Quality of life people living with HIV/AIDS: outpatient in Kramat 128 Hospital Jakarta.
TL;DR: Higher CD4 levels, undetectable VL, and longer ARV therapy will increase patient's QOL, which will make the patient have ability to cope with illness and a better QOL can be taken as indicator of successful ARV treatment.
Journal ArticleDOI
Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia.
Ivo N. SahBandar,Kiyomi Takahashi,Zubairi Djoerban,Iman Firmansyah,Satoshi Naganawa,Kazushi Motomura,Hironori Sato,Katsuhiko Kitamura,Herdiman T. Pohan,Shigehiro Sato +9 more
TL;DR: This study shows the current predominant subtype is CRF01_AE in every risk group, with a decreasing number of pure subtype B, and the first identification of CRF 01_AE/B recombinant forms among HIV-1-seropositive Indonesians.
Journal ArticleDOI
Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis.
Kathryn E. Lancaster,Irving F. Hoffman,Brett Hanscom,Tran Viet Ha,Kostyantyn Dumchev,Hepa Susami,Scott Rose,Vivian F. Go,Sarah A. Reifeis,Katie R. Mollan,Michael G. Hudgens,Estelle Piwowar-Manning,Paul G. Richardson,Sergii Dvoriak,Zubairi Djoerban,Tetiana Kiriazova,Oleksandr Zeziulin,Samsuridjal Djauzi,Chu Viet Ahn,Carl A. Latkin,David S. Metzger,David N. Burns,Jeremy Sugarman,Steffanie A. Strathdee,Susan H. Eshleman,William Clarke,Deborah Donnell,Lynda Emel,Lisa E. Sunner,Laura McKinstry,Nirupama Sista,Erica L. Hamilton,Jonathan Lucas,Bui D Duong,Nguyen Van Vuong,Riza Sarasvita,William C. Miller,Hptn (PopART) Study Team +37 more
TL;DR: People who inject drugs experience high HIV incidence and face significant barriers to engagement in HIV care and substance use treatment, so understanding differences in the risk structure for HIV transmission and disease progression among PWID is essential in developing and effectively targeting intervention strategies of HIV treatment as prevention.
Journal ArticleDOI
Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs
Jessica M. Fogel,Yinfeng Zhang,Philip J. Palumbo,Xu Guo,William Clarke,Autumn Breaud,Paul G. Richardson,Estelle Piwowar-Manning,Erica L. Hamilton,Tran Viet Ha,Kostyantyn Dumchev,Zubairi Djoerban,Irving F. Hoffman,Brett Hanscom,William C. Miller,Susan H. Eshleman +15 more
TL;DR: This study shows that self-reported data on HIV testing history and ART may not be accurate and that ARV drug testing can help identify persons who are aware of their HIV-positive status and are on ART.